Market Research Reports

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

206pages
Published Date: 2014-02-03
 

Description


The life sciences BPO market comprises services offered by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies.  Pharmaceutical companies are now forming long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals thus spurring the demand for life sciences BPO services worldwide. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for effective outcomes.

The research report on life sciences BPO provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of life sciences BPO on the basis of different CRO and CMO services. The CRO services comprises clinical data management, monitoring, medical writing, regulatory services, pharmacovigilance, bio-statistics, drug discovery and pre-clinical tests. The CMO services include API manufacturing, finished dosage formulation development and manufacturing and packaging.

The global life sciences BPO market has been segmented based on all the above-mentioned parameters and market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the segments, in terms of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The CAGR (%) of each market segment in the life sciences BPO industry for the forecast period 2013 to 2019 has also been provided along with market size estimations.

The report exclusively studies all the life sciences BPO segments with respect to geography. Under the geographic section, we have covered four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (ROW). Moreover, the European market for life sciences BPO has been further studied by various countries including U.K., Germany, France, Spain, Italy and Rest of Europe (ROE).

The market overview section gives a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global life sciences BPO market. The section also covers opportunities, market attractiveness analysis and Porter’s Five Forces analysis for the market participants.

The report concludes with the competitive landscape and company profiles of major market players contributing to the global life sciences BPO market. These market players have been profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Catalent Pharma Solutions, Inc., PRA International Inc., Covance Inc., Cognizant Technology Solutions, Quintiles Transnational Corporation, Parexel International Corporation, DSM, Charles River Laboratories, Piramal Healthcare and Boehringer Ingelheim GmbH.
The global life sciences BPO market is segmented as follows:

Global Life Sciences BPO Market, by Segments
  • Pharmaceutical Outsourcing Market
    • Contract Manufacturing Organizations (CMOs)
      • Active Pharmaceutical Ingredients (APIs) Manufacturing
      • Finished Dosage Formulation (FDF) Development and Manufacturing
      • Packaging
  • Contract Research Organizations (CROs)
    • Drug Discovery
    • Pre-Clinical Studies
    • Clinical Studies
    • Medical Writing
    • Clinical Data Management (CDM)
    • Bio-Statistics
    • Risk Based Monitoring
    • Site Management
    • Pharmacovigilance
    • Regulatory Services
    • Protocol Development
  • Others
    • Contract Sales Organizations (CSOs)
Global Life Sciences BPO Market, by Geography
  • North America
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • ROE
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents


Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019)
2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)

Chapter 3 Global Life Sciences BPO Market Dynamics
3.1 Introduction
      3.1.1 Drivers
               3.1.1.1 Rising cost of R&D and decline in productivity
               3.1.1.2 Patent expirations to boost CMO industry growth
               3.1.1.3 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions
               3.1.1.4 Restructuring of pharmaceutical production
      3.1.2 Restraints
               3.1.2.1 Data safety concerns
               3.1.2.2 Stringent and varied regulatory approval processes in different countries
               3.1.2.3 Unforeseen Costs has marred the growth of CRO industry
      3.1.3 Opportunities
               3.1.3.1 Biologics
               3.1.3.2 Emerging markets
3.2 Value Chain Analysis
      3.2.1 People Skills and Challenges for Life Sciences BPO Services:
      3.2.2 Pharmaceutical Outsourcing
      3.2.3 Contract Research Outsourcing Market:
      3.2.4 Value Chain Analysis: Contract Research Outsourcing Market
      3.2.5 Contract Research Outsourcing Services (%), 2012
               3.2.5.1 Contract Research Outsourcing Services (%), 2012
      3.2.6 Pharmacovigilance
               3.2.6.1 Value Chain Analysis: Pharmacovigilance
      3.2.7 Biostatistics
              3.2.7.1 Value Chain Analysis: Biostatistics
      3.2.8 Risk-based Monitoring
              3.2.8.1 Value Chain Analysis: Risk based Monitoring
      3.2.9 Study Design and Protocol Development
              3.2.9.1 Value Chain Analysis: Study Design and Protocol Development
      3.2.10 Medical Writing
                3.2.10.1 Value Chain Analysis: Medical Writing
      3.2.11 Clinical Data Management
                3.2.11.1 Value Chain Analysis: Clinical Data Management
      3.2.12 Site Management
                3.2.12.1 Value Chain Analysis: Site Management
      3.2.13 Regulatory Services
                3.2.13.1 Value Chain Analysis: Regulatory Services
3.3 Porter’s Five Force Analysis: Global Life sciences BPO Market
      3.3.1 Bargaining Power of Suppliers
      3.3.2 Bargaining Power of Buyers
      3.3.3 Threat of New Entrants
      3.3.4 Threat of Substitutes
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography
      3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe
      3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography

Chapter 4 Global Life Sciences BPO Market, by Segments
4.1 Overview
4.2 Pharmaceutical Outsourcing
      4.2.1 Contract Manufacturing Outsourcing
              4.2.1.1 Active Pharmaceutical Ingredients (API) Manufacturing
                         4.2.1.1.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.1.2 Final Dosage Form (FDF) Manufacturing
                         4.2.1.2.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.1.3 Packaging
                         4.2.1.3.1 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
     4.2.2 Contract Research Outsourcing
              4.2.2.1 Drug Discovery
                         4.2.2.1.1 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.2 Pre-Clinical Studies
                         4.2.2.2.1 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.3 Early Phase Clinical Research Services (Phase I / IIa)
                         4.2.2.3.1 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.4 Phase IIb / IIIa
                         4.2.2.4.1 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.5 Phase IIIb / IV (Peri/Post Approval Phase / Post Marketing Surveillance)
                         4.2.2.5.1 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.6 Medical Writing
                         4.2.2.6.1 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.7 Pharmacovigilance
                         4.2.2.7.1 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.8 Clinical Data Management
                         4.2.2.8.1 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.9 Regulatory Services
                         4.2.2.9.1 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.10 Clinical Monitoring
                           4.2.2.10.1 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.11 Biostatistics
                           4.2.2.11.1 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.12 Protocol Development
                           4.2.2.12.1 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.2.13 Site Management
                           4.2.2.13.1 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)

Chapter 5 Global Life Sciences BPO Market, by Geography
5.1 Overview
       5.1.1 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
       5.1.2 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
       5.2.1 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3 Europe
       5.3.1 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
       5.3.2 Germany
               5.3.2.1 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
               5.3.2.2 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
               5.3.2.3 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.3 U.K.
                5.3.3.1 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
                5.3.3.2 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2-019 (USD Billion)
                5.3.3.3 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.4 France
                5.3.4.1 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
                5.3.4.2 France Contract Manufacturing Outsourcing Service Market, 2011 – 2019 (USD Million)
                5.3.4.3 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.5 Italy
               5.3.5.1 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
               5.3.5.2 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
               5.3.5.3 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.6 Spain
               5.3.6.1 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
               5.3.6.2 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
               5.3.6.3 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.7 Switzerland
                5.3.7.1 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
                5.3.7.2 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
                5.3.7.3 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
       5.3.8 Rest of Europe (ROE)
                5.3.8.1 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
                5.3.8.2 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
                5.3.8.3 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
       5.4.1 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.5 RoW
       5.5.1 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

Chapter 6 Global Life Sciences BPO Market Share Analysis
6.1 Market Share Analysis by Key Players of Global CRO Market
       6.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%)
6.2 Market Share Analysis by Key Players of Global CMO Market
       6.2.1 Global CMO Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Success Strategies
       7.1.1 Expand Market into Emerging Countries
       7.1.2 Ensure Data Confidentiality and Regulatory Compliance
       7.1.3 Timely Entry in the Market
       7.1.4 Offer a Wide Range of Research and Manufacturing Services
       7.1.5 Developing Strategic Alliances and Partnerships With Pharmaceutical and Biotechnology Companies
       7.1.6 Risk Management

Chapter 8 Company Profiles
8.1 Accenture, Plc
       8.1.1 Company Overview
       8.1.2 Financial Overview
       8.1.3 Product Portfolio
       8.1.4 Business Strategies
               8.1.4.1 Mergers and acquisitions
       8.1.5 Recent Developments
8.2 Boehringer Ingelheim GmbH
       8.2.1 Company Overview
       8.2.2 Financial Overview
       8.2.3 Product Portfolio
       8.2.4 Business Strategies
               8.2.4.1 Research And Development For Medical Innovation
       8.2.5 Recent Developments
8.3 Catalent Pharma Solutions, Inc.
       8.3.1 Company Overview
       8.3.2 Financial Overview
       8.3.3 Product Portfolio
       8.3.4 Business Strategies
                8.3.4.1 Geographical expansion of business
                8.3.4.2 Diversification of product portfolio
       8.3.5 Recent Developments
8.4 Charles River Laboratories International, Inc. (CRL)
       8.4.1 Company Overview
       8.4.2 Financial Overview
       8.4.3 Product Portfolio
       8.4.4 Business Strategies
               8.4.4.1 Expansion of services offered
               8.4.4.2 New product launches and Innovation
               8.4.4.3 Strategic acquisitions
       8.4.5 Recent Developments
8.5 Cognizant Technology Solutions
       8.5.1 Company Overview
       8.5.2 Financial Overview
       8.5.3 Product Portfolio
       8.5.4 Business Strategies
                8.5.4.1 Expansion of geographical footprint
                8.5.4.2 Expansion product portfolio
                8.5.4.3 Highly-skilled manpower
                8.5.4.4 Strategic acquisitions
       8.5.5 Recent Developments
8.6 Covance, Inc.
       8.6.1 Company Overview
       8.6.2 Financial Overview
       8.6.3 Product Portfolio
       8.6.4 Business Strategies
               8.6.4.1 New product development and innovation
               8.6.4.2 Agreements and collaborations
               8.6.4.3 Strategic acquisitions
               8.6.4.4 Geographical expansion of business
       8.6.5 Recent Developments
8.7 DSM
       8.7.1 Company Overview
       8.7.2 Financial Overview
       8.7.3 Product Portfolio
       8.7.4 Business Strategies
               8.7.4.1 Strategic acquisitions
       8.7.5 Recent Developments
8.8 Fareva
       8.8.1 Company Overview
       8.8.2 Product Portfolio
       8.8.3 Business Strategies
               8.8.3.1 Extensive product portfolio
               8.8.3.2 Safety environment for staff
               8.8.3.3 Commitment to quality
       8.8.4 Recent Developments
8.9 ICON, Plc
       8.9.1 Company Overview
       8.9.2 Financial Overview
       8.9.3 Product Portfolio
       8.9.4 Business Strategies
               8.9.4.1 Business expansion in APAC region
               8.9.4.2 Expansion of services offered
       8.9.5 Recent Developments
8.10 Infosys
       8.10.1 Company Overview
       8.10.2 Financial Overview
       8.10.3 Product Portfolio
       8.10.4 Business Strategies
                 8.10.4.1 Extensive product portfolio
                 8.10.4.2 Geographical expansion of business
       8.10.5 Recent Developments
8.11 International Business Machines Corporation
       8.11.1 Company overview
       8.11.2 Financial overview
       8.11.3 Product Portfolio
       8.11.4 Business strategies
                  8.11.4.1 Focus on increasing facilities for predictive analytics
                  8.11.4.2 Geographic Expansion
       8.11.5 Recent developments
8.12 Lonza Group
       8.12.1 Company Overview
       8.12.2 Financial Overview
       8.12.3 Product Portfolio
       8.12.4 Business Strategies
                 8.12.4.1 Investment in emerging economies
                 8.12.4.2 Mergers and acquisitions
       8.12.5 Recent Developments
8.13 Pharmaceutical Product Development, Inc. (PPD, Inc.)
       8.13.1 Company Overview
       8.13.2 Financial Overview
       8.13.3 Product Portfolio
       8.13.4 Business Strategies
                 8.13.4.1 Expanding geographic presence
                 8.13.4.2 Incorporation of innovative technologies
                 8.13.4.3 Strategic acquisitions
                 8.13.4.4 New product launch and innovation
       8.13.5 Recent Developments
8.14 Parexel International Corporation
       8.14.1 Company Overview
       8.14.2 Financial Overview
       8.14.3 Product Portfolio
       8.14.4 Business Strategies
                 8.14.4.1 Strong presence in Asia and emerging markets
                 8.14.4.2 Strategic alliances
                 8.14.4.3 Mergers & Acquisitions
       8.14.5 Recent Developments
8.15 Patheon, Inc.
       8.15.1 Company Overview
       8.15.2 Financial Overview
       8.15.3 Product Portfolio
       8.15.4 Business Strategies
                 8.15.4.1 Strategic acquisitions
                 8.15.4.2 Geographical expansion of business
       8.15.5 Recent Developments
8.16 Piramal Healthcare
       8.16.1 Company Overview
       8.16.2 Financial Overview
       8.16.3 Product Portfolio
       8.16.4 Business Strategies
                 8.16.4.1 Expansion of services offered
       8.16.5 Recent Developments
8.17 PRA International, Inc.
       8.17.1 Company Overview
       8.17.2 Financial Overview
       8.17.3 Product Portfolio
       8.17.4 Business Strategies
                 8.17.4.1 Mergers and acquisitions
       8.17.5 Recent Developments
8.18 Quintiles Transnational Corporation
       8.18.1 Company Overview
       8.18.2 Financial Overview
       8.18.3 Product Portfolio
       8.18.4 Business Strategies
                 8.18.4.1 Expansion of services
                 8.18.4.2 Acquisitions and partnerships
                 8.18.4.3 Innovation in services offered
       8.18.5 Recent Developments
8.19 Wipro Limited
       8.19.1 Company Overview
       8.19.2 Financial Overview
       8.19.3 Product Portfolio
       8.19.4 Business Strategies
                 8.19.4.1 Geographical Expansion

Chapter 9 List of the Companies
9.1 List of Companies Offering Contract Research Outsourcing Services in North America.
9.3 List of Companies Offering Contract Research Outsourcing Services in Europe.
       9.3.1 List of Contract Research Organizations in France
       9.3.2 List of Contract Research Organizations in Italy
       9.3.4 List of Contract Research Organizations in Germany
       9.3.5 List of Contract Research Organizations in Spain
       9.3.6 List of Contract Research Organizations in United Kingdom
       9.3.7 List of Contract Research Organizations in Switzerland

List of Figures

FIG. 1 Global Life Sciences BPO Services : Market Segmentation
FIG. 2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
FIG. 3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 5 Global Life Sciences BPO Market: Drivers and Restraints
FIG. 6 Value Chain Analysis: Pharmaceutical Outsourcing
FIG. 7 Value Chain Analysis: Contract Research Outsourcing Market
FIG. 8 Contract Research Outsourcing Services (%), 2012
FIG. 9 Value Chain Analysis: Pharmacovigilance
FIG. 10 Value Chain Analysis: Biostatistics
FIG. 11 Value Chain Analysis: Risk based Monitoring
FIG. 12 Value Chain Analysis: Study Design and Protocol Development
FIG. 13 Value Chain Analysis: Medical Writing
FIG. 14 Value Chain Analysis: Clinical Data Management
FIG. 15 Value Chain Analysis: Site Management
FIG. 16 Value Chain Analysis: Regulatory Services
FIG. 17 Porter’s Five Force Analysis: Global Life sciences BPO Market
FIG. 18 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
FIG. 19 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012
FIG. 20 Pharmaceutical Contract Manufacturing Outsourcing, Flow of Services
FIG. 21 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 22 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 23 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
FIG. 24 Pharmaceutical Contract Research Outsourcing, Flow of Services
FIG. 25 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 26 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 27 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 28 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 29 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 30 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 31 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 32 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 33 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 34 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 35 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 36 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 37 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 38 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
FIG. 39 Global CRO: Market Share, by Key Players, 2012 (%)
FIG. 40 Global CMO: Market Share, by Key Players, 2012 (%)
FIG. 41 Accenture, Plc.: Annual Revenue (USD Billion) 2010 – 2012
FIG. 42 Boehringer Ingelheim GmbH: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 43 Catalent Pharma Solutions, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 44 Charles River Laboratories International, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 45 Cognizant Technology Solutions: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 46 COVANCE, Inc.: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 47 DSM: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 48 ICON, PLC: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 49 Infosys: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 50 IBM Corporation: Annual Revenue (USD Billion) 2010 – 2012
FIG. 51 Lonza Group: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 52 Parexel International Corporation: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 53 Patheon, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 54 Piramal Healthcare: Annual Sales Revenue, USD Million (2010 – 2012)
FIG. 55 Quintiles Transnational Corporation: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 56 Wipro Limited: Annual Revenue (USD Million) 2010 – 2012

List of Tables

TABLE 1 Market Snapshot : Life Sciences BPO Market
TABLE 2 Research and Development Spending per New Drug (2012)
TABLE 3 Global Life Sciences BPO Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 4 Global Pharmaceutical Contract Manufacturing Outsourcing (CMO) Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 5 Global Contract Research Outsourcing Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 6 Outsourced Drug Discovery and Development Expenditures, by Types, USD Billion
TABLE 7 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
TABLE 8 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 9 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 10 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 11 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 12 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 13 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 14 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 15 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 16 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 17 France Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 18 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 19 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 20 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 21 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 22 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 23 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 24 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 25 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 26 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 27 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 28 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 29 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 30 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 31 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 32 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

Enquiry Before Buying


Free Market Analysis


Economic burden, increased financial crisis and technological advances has compelled all pharmaceutical, biotechnology and life science companies to outsource their R&D activities and manufacturing processes in order to achieve their cost benefits and save time.In recent years, large number of life science companies has modified their traditional drug manufacturing operationswith more focus now on their core R&D activities and manufacturing processes via outsourcing. At present, new outsourcing strategies and types of services are developing in almost every stage of research and manufacturing process. For instance, a virtually integrated, cross-functional outsourcing of drug discovery research is currently being considered as a latest outsourcing model, especially for small molecule drug discovery. In addition, genomics &proteomics research and gene–silencing technology are now being widely used for target identification and validation of complex disease targets.

Global Life Sciences BPO market includes Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and others that compriseContract Sales Organization (CSO). The contract manufacturing organizations market is expected to see the highest growth rate during the forecast period and also accounted for the largest market share in the year 2012. This market holds immense growth owing to the rise in demand for generic drugs, increase in R&D investment by life sciences companies. In addition, a rise in the number ofblock buster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. The CMO market comprises contract API (Active Pharmaceutical Ingredients) manufacturing, contract FDF (Finished Dosage Formulations) manufacturing and packaging.Among these, contract FDF manufacturing segment is expected to have a healthy growth rate during the forecast period. The CRO market is also expected to display a healthy growth rate after CMO market. The CRO market comprises of various segments such as drug discovery, pre-clinical studies, clinical trial phases, medical writing, clinical data management, pharmacovigilance, regulatory services, site management, protocol development, monitoring and bio-statistics. Among these, clinical data management segment is expected to have a strong growth rate in coming years. This growth has been attributed to its high data complexities, high cost involvement and requirement of skilled & trained professionals.

Geographically, the North American region constituted the largest market for global life sciences BPOmarket in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of over 21.2% from 2013 to 2019. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs andother overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.

The major players of this market are CatalentPharma Solutions, PRA International, Covance, Quintiles, Parexel, DSM, Charles River Laboratories, Piramal Healthcare and BoehringerIngelheim.

global-life-sciences-bpomarket-by-segments-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research